tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Danielle Brill, 139 are a BUY (80.81%), 28 are a HOLD (16.28%), 5 are a SELL (2.91%).
Analyst Danielle Brill works at RAYMOND JAMES with a stock forecast success ratio of 41.93% fulfilled within 163.2 days on average.
Danielle Brill’s has documented 319 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 29-Nov-2023.
Analyst best performing recommendations are on IMVT (IMMUNOVANT ).
The best stock recommendation documented was for XLRN (ACCELERON PHARMA) at 1/8/2020. The price target of $73 was fulfilled within 20 days with a profit of $19.46 (36.35%) receiving and performance score of 18.17.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
25
$8.01 (47.15%)
29
30 days ago
5/8 (62.5%)
$7.16 (40.13%)
26
Buy
30
$13.01 (76.57%)
40
1 months 11 days ago
16/19 (84.21%)
$10.44 (53.37%)
184
Buy
39
$22.01 (129.55%)
40
1 months 27 days ago
6/10 (60%)
$15.25 (64.21%)
94
Buy
33
$16.01 (94.23%)
33
1 months 27 days ago
8/19 (42.11%)
$9.25 (38.95%)
119
Buy
36
$19.01 (111.89%)
1 months 27 days ago
0/1 (0%)
$12.25 (51.58%)
Which stock is Danielle Brill is most bullish on?
Which stock is Danielle Brill is most reserved on?
What Year was the first public recommendation made by Danielle Brill?
